比美替尼，又称Mektovi和ARY-162，是Array Biopharma开发的用于治疗各种癌症的抗癌小分子。比美替尼是MEK的选择性抑制剂，是肿瘤促进MAPK途径的中心激酶。
2,3,4-Trifluorobenzoic acid
4-Amino-2,3-difluoro-5-nitrobenzoic acid
Methyl 4-amino-2,3-difluoro-5-nitrobenzoate
2,3,4-Trifluoro-5-nitrobenzoic acid
Methyl 2,4-diamino-3-fluoro-5-nitrobenzoate
Methyl 5-amino-4-fluoro-1-methyl-1H-benzo[d]imidazole-6-carboxylate
4-Bromo-2-fluoro-1-iodobenzene
5-((4-Bromo-2-fluorophenyl)amino)-4-fluoro-N-(2-hydroxyethoxy)-1-methyl-1H-benzo[d]imidazole-6-carboxamide
O-(2-(Vinyloxy)ethyl)hydroxylamine
Methyl 2,4,5-triamino-3-fluorobenzoate
Methyl 6-((4-bromo-2-fluorophenyl)amino)-7-fluoro-1H-benzo[d]imidazole-5-carboxylate
O-[2-(tert-Butoxy)ethyl]hydroxylamine
5-((4-Bromo-2-fluorophenyl)amino)-4-fluoro-1-methyl-1H-benzo[d]imidazole-6-carboxylic acid
Methyl 5-((4-bromo-2-fluorophenyl)amino)-4-fluoro-1-methyl-1H-benzo[d]imidazole-6-carboxylate
Methyl 4-amino-3-fluoro-2-((2-fluorophenyl)amino)-5-nitrobenzoate
5-((4-bromo-2-fluorophenyl)amino)-4-fluoro-1-methyl-N-(2-(vinyloxy)ethoxy)-1H-benzo[d]imidazole-6-carboxamide
